Browse By Cancer Type Result Page of OvirusTdb

The total number of records retrieved from this search are 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_59AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining0.01 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_60AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining0.1 MOI90% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_61AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining1 MOI40% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_62AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining10 MOI2% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_63AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.001 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_64AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.01 MOI90% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_65AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.1 MOI60% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_66AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining1 MOI4% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_67AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining10 MOI1% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_68AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.001 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_69AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.01 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_70AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.1 MOI96% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_71AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining1 MOI80% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_72AdenovirusAd5WS1DNAAdenoviridaeE1B55K-deleted mutant driven by the E1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining10 MOI20% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_73AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.01 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_74AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.1 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_75AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining1 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_76AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining10 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_77AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.01 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_78AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.1 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_79AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining1 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_80AdenovirusAdLacZDNAAdenoviridaeE1/E3-deleted mutantYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining10 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_81AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining0.01 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_82AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining0.1 MOI85% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_83AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining1 MOI35% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_84AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (YB-1 gene knockdown)NANACrystal violet staining10 MOI1% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_85AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.001 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_86AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.01 MOI90% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_87AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining0.1 MOI20% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_88AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining1 MOI2% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_89AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged YB-1 gene overexpressed)NANACrystal violet staining10 MOI1% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_90AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.001 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_91AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.01 MOI100% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_92AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining0.1 MOI94% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_93AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining1 MOI75% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_94AdenovirusAd5GS3DNAAdenoviridaeE1B55K-deleted mutant driven by the MDR1 promoterYesNoNoNAHuman breast cancer lineMCF-7 (HA-tagged mutant YB-1(S102A) gene overexpression, mutation at Akt phosphorylation site which leads to failed nuclear translocation)NANACrystal violet staining10 MOI16% cancer cell viabilityNoNoNA No responseNANANANA26515462
OV_2212Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMDA-MB-4351.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI50% cell survival after day 1NoNoNA No responseNACaspase activationNANA22108767
OV_2213Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMDA-MB-4351.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI55% cell survival after day 2NoNoNA No responseNACaspase activationNANA22108767
OV_2214Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMDA-MB-4351.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI60% cell survival after day 3NoNoNA No responseNACaspase activationNANA22108767
OV_2215Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMDA-MB-4351.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI30% cell survival after day 4NoNoNA No responseNACaspase activationNANA22108767
OV_2216Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMDA-MB-4351.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI100% cell death after day 5NoNoNA No responseNACaspase activationNANA22108767
OV_2217Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMDA-MB-4351.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI40% cell survival after day 1NoNoNA No responseNACaspase activationNANA22108767
OV_2218Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMDA-MB-4351.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI20% cell survival after day 2NoNoNA No responseNACaspase activationNANA22108767
OV_2219Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMDA-MB-4351.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI10% cell survival after day 3NoNoNA No responseNACaspase activationNANA22108767
OV_2220Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMDA-MB-4351.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI100% cell death after day 4NoNoNA No responseNACaspase activationNANA22108767
OV_2221Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMDA-MB-4351.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI100% cell death after day 5NoNoNA No responseNACaspase activationNANA22108767
OV_2222Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-71.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI100% cell survival after day 1NoNoNA No responseNACaspase activationNANA22108767
OV_2223Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-71.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI100% cell survival after day 2NoNoNA No responseNACaspase activationNANA22108767
OV_2224Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-71.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI70% cell survival after day 3NoNoNA No responseNACaspase activationNANA22108767
OV_2225Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-71.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI40% cell survival after day 4NoNoNA No responseNACaspase activationNANA22108767
OV_2226Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-71.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI20% cell death after day 5NoNoNA No responseNACaspase activationNANA22108767
OV_2227Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-71.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI90% cell survival after day 1NoNoNA No responseNACaspase activationNANA22108767
OV_2228Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-71.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI60% cell survival after day 2NoNoNA No responseNACaspase activationNANA22108767
OV_2229Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-71.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI30% cell survival after day 3NoNoNA No responseNACaspase activationNANA22108767
OV_2230Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-71.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI10% cell survival after day 4NoNoNA No responseNACaspase activationNANA22108767
OV_2231Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-71.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI100% cell death after day 5NoNoNA No responseNACaspase activationNANA22108767
OV_2232Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineSK-BR-31.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI90% cell survival after day 1NoNoNA No responseNACaspase activationNANA22108767
OV_2233Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineSK-BR-31.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI60% cell survival after day 2NoNoNA No responseNACaspase activationNANA22108767
OV_2234Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineSK-BR-31.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI55% cell survival after day 3NoNoNA No responseNACaspase activationNANA22108767
OV_2235Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineSK-BR-31.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI40% cell survival after day 4NoNoNA No responseNACaspase activationNANA22108767
OV_2236Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineSK-BR-31.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI100% cell death after day 5NoNoNA No responseNACaspase activationNANA22108767
OV_2237Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineSK-BR-31.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI60% cell survival after day 1NoNoNA No responseNACaspase activationNANA22108767
OV_2238Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineSK-BR-31.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI40% cell survival after day 2NoNoNA No responseNACaspase activationNANA22108767
OV_2239Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineSK-BR-31.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI20% cell survival after day 3NoNoNA No responseNACaspase activationNANA22108767
OV_2240Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineSK-BR-31.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI10% cell survival after day 4NoNoNA No responseNACaspase activationNANA22108767
OV_2241Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineSK-BR-31.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI100% cell death after day 5NoNoNA No responseNACaspase activationNANA22108767
OV_2242Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-10A1.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI100% cell survival after day 1NoNoNA No responseNACaspase activationNANA22108767
OV_2243Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-10A1.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI100% cell survival after day 2NoNoNA No responseNACaspase activationNANA22108767
OV_2244Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-10A1.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI100% cell survival after day 3NoNoNA No responseNACaspase activationNANA22108767
OV_2245Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-10A1.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI100% cell survival after day 4NoNoNA No responseNACaspase activationNANA22108767
OV_2246Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-10A1.0E+5 cells per wellNAX-gal staining and MTT assay0.01 MOI100% cell survival after day 5NoNoNA No responseNACaspase activationNANA22108767
OV_2247Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-10A1.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI100% cell survival after day 1NoNoNA No responseNACaspase activationNANA22108767
OV_2248Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-10A1.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI100% cell survival after day 2NoNoNA No responseNACaspase activationNANA22108767
OV_2249Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-10A1.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI100% cell survival after day 3NoNoNA No responseNACaspase activationNANA22108767
OV_2250Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-10A1.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI90% cell survival after day 4NoNoNA No responseNACaspase activationNANA22108767
OV_2251Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMCF-10A1.0E+5 cells per wellNAX-gal staining and MTT assay0.1 MOI80% cell survival after day 5NoNoNA No responseNACaspase activationNANA22108767
OV_2252Herpes simplex virusHSV-1-G47-deltaDNAHerpesviridaeMutant for Gamma34.5, ICP6 and alpha47 geneYesNoNoState key laboratory of oncology ChinaHuman breast cancer cell lineMDA-MB-435NANANANANABALB/c nude mice xenograft for MDA-MB-435(1.0E+6 × 10⁶)2.0E+7 pfuNA Tumor volume decreased by 9 fold after 56 daysIntratumoralCaspase activationNANA22108767
OV_2442Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2443Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2444Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2445Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 7NoNoNA No responseNANANANA22258815
OV_2446Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 9NoNoNA No responseNANANANA22258815
OV_2482Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI90% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2483Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI90% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2484Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI90% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2485Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI90% cell survival after day 7NoNoNA No responseNANANANA22258815
OV_2518Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer1 MOI70% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2519Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer1 MOI10% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2520Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer1 MOI10% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2521Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer1 MOI10% cell survival after day 7NoNoNA No responseNANANANA22258815
OV_2579AdenovirusCNHK600-IL24DNAAdenoviridaeDeletion of E1B gene and addition of IL-24 geneYesNoVirus expressing IL-24 geneShanghai laboratory animal center, ChinaHuman breast cancer cell lineMDA-MB-2311.0E+5 cells per wellNAMTT assay0.1 MOI100% cell survivalNoNoNA No responseNAInduction of apoptosis in cancerNANA22640485
OV_2580AdenovirusCNHK600-IL24DNAAdenoviridaeDeletion of E1B gene and addition of IL-24 geneYesNoVirus expressing IL-24 geneShanghai laboratory animal center, ChinaHuman breast cancer cell lineMDA-MB-2311.0E+5 cells per wellNAMTT assay1 MOI100% cell survivalNoNoNA No responseNAInduction of apoptosis in cancerNANA22640485
OV_2581AdenovirusCNHK600-IL24DNAAdenoviridaeDeletion of E1B gene and addition of IL-24 geneYesNoVirus expressing IL-24 geneShanghai laboratory animal center, ChinaHuman breast cancer cell lineMDA-MB-2311.0E+5 cells per wellNAMTT assay10 MOI50% cell survivalNoNoNA No responseNAInduction of apoptosis in cancerNANA22640485
OV_2582AdenovirusCNHK600-IL24DNAAdenoviridaeDeletion of E1B gene and addition of IL-24 geneYesNoVirus expressing IL-24 geneShanghai laboratory animal center, ChinaHuman breast cancer cell lineMDA-MB-2311.0E+5 cells per wellNAMTT assay100 MOI20% cell survivalNoNoNA No responseNAInduction of apoptosis in cancerNANA22640485
OV_2583AdenovirusCNHK600-IL24DNAAdenoviridaeDeletion of E1B gene and addition of IL-24 geneYesNoVirus expressing IL-24 geneShanghai laboratory animal center, ChinaHuman breast cancer cell lineMDA-MB-2311.0E+5 cells per wellNAMTT assay1000 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis in cancerNANA22640485
OV_2584AdenovirusCNHK600-IL24DNAAdenoviridaeDeletion of E1B gene and addition of IL-24 geneYesNoVirus expressing IL-24 geneShanghai laboratory animal center, ChinaHuman breast cancer cell lineMDA-MB-2311.0E+5 cells per wellNAMTT assay10000 MOIAll cells are deadNoNoNA No responseNAInduction of apoptosis in cancerNANA22640485
OV_2585AdenovirusCNHK600-IL24DNAAdenoviridaeDeletion of E1B gene and addition of IL-24 geneYesNoVirus expressing IL-24 geneShanghai laboratory animal center, ChinaHuman breast cancer cell lineMDA-MB-231NANANANANANu/Nu female mice orthotopic for MDA-MB-231 cell line (8.0E+7 cells)1.0E+8 pfuNA Tumor volume comes to 1000mm as compared to normal 2000 after 42 daysIntratumoralInduction of apoptosis in cancerNANA22640485
OV_2586AdenovirusCNHK600-IL24DNAAdenoviridaeDeletion of E1B gene and addition of IL-24 geneYesNoVirus expressing IL-24 geneShanghai laboratory animal center, ChinaHuman breast cancer cell lineMDA-MB-231NANANANANANu/Nu female mice orthotopic for MDA-MB-231 cell line (8.0E+7 cells)2.0E+8 pfuNA Tumor volume comes to below 1000mm as compared to normal 2000 after 42 daysIntratumoralInduction of apoptosis in cancerNANA22640485
OV_2587AdenovirusCNHK600-IL24DNAAdenoviridaeDeletion of E1B gene and addition of IL-24 geneYesNoVirus expressing IL-24 geneShanghai laboratory animal center, ChinaHuman breast cancer cell lineMDA-MB-231NANANANANANu/Nu female mice orthotopic for MDA-MB-231 cell line (8.0E+7 cells)4.0E+8 pfuNA Tumor volume comes to 500mm as compared to normal 2000 after 42 daysIntratumoralInduction of apoptosis in cancerUpregulation of GADD34NA22640485
OV_2632AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseYesNoNoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI80% cell survival after 3 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515